The largest DNA ancestry service in the world Sign in Register Kit

Genomics and the Consumer:

The Present and Future of Personalized Medicine

Hosted by California State Senator Alex Padilla and 23andMe

Wednesday, July 14, 2010

Video Recordings
Opening Remarks
California State Senator Alex Padilla
Welcome
Anne Wojcicki, 23andMe
P4 Medicine (Predictive, Personalized, Preventive, & Participatory):
Catalyzing a Revolution from Reactive to Proactive Medicine
Leroy Hood, MD, Institute for Systems Biology
Leroy Hood - Q&A
Panel 1: Integrating Personalized Medicine Into Clinical Practice
Moderated by David Ewing Duncan, UC Berkeley
Edward Abrahams, PhD, Personalized Medicine Coalition
Uta Francke, MD, Stanford University
Mark Hoffman, PhD, Cerner Corporation
Kelly Ormond, MS, CGC, Stanford University
Panel 1 - Q&A
Panel 2: The Potential and Pitfalls of Genomic Research
Moderated by Thomas Goetz, Wired
Joanna Mountain, PhD, 23andMe
Robert Shelton, PrivateAccess
Brad Templeton, Electronic Frontier Foundation
David Winickoff, JD, UC Berkeley
Panel 2 - Q&A
The Regulatory Landscape for Personal Genomics
Dan Vorhaus, JD, Robinson, Bradshaw & Hinson
Dan Vorhaus - Q&A
Panel 3: Risks and Benefits of Direct-to-Consumer Access
to Genetic Information
Moderated by California State Senator Alex Padilla
Misha Angrist, PhD, Duke University
Sandra Lee, PhD, Stanford Center for Biomedical Ethics
Amy McGuire, JD, PhD, Baylor College of Medicine
Panel 3 - Q&A
Summary & Closing Remarks
California State Senator Alex Padilla
Anne Wojcicki, 23andMe

Wednesday, July 14, 2010
9:30am — 5:00pm

Hyatt Regency San Francisco Airport
1333 Bayshore Highway
Burlingame, CA 94010

Attendance is FREE
Lunch Provided
Space is limited

RSVP by July 7, 2010
rsvp@23andme.com

Keynote Speaker: Leroy Hood, MD

"P4 Medicine (Predictive, Personalized, Preventive, and Participatory): Catalyzing a Revolution from Reactive to Proactive"

Topics:
  • The Regulatory Landscape for Personal Genomics
  • The Potential and Pitfalls of Genomic Research
  • Integrating Personalized Medicine into Clinical Practice
  • Risks and Benefits of Consumer Access to Genetic Information

download full agenda